The global market for Nicotinamide Mononucleotide (NMN) Cosmetics was valued at US$ 305 million in the year 2024 and is projected to reach a revised size of US$ 1158 million by 2031, growing at a CAGR of 20.8% during the forecast period.

Nicotinamide Mononucleotide (NMN) Cosmetics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nicotinamide Mononucleotide (NMN) Cosmetics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The Nicotinamide Mononucleotide (NMN) Cosmetics market refers to the segment of skincare and personal care products in which NMN is used as a core functional active to deliver anti-aging, moisturizing and “skin vitality” benefits. In this context, NMN is positioned as a next-generation derivative of the vitamin B3 family and a direct precursor of NAD⁺, a coenzyme involved in cellular energy metabolism and DNA repair; patents on NMN-containing cosmetic compositions describe its use to provide long-lasting moisturization and to improve visible signs of skin aging such as wrinkles, sagging and roughness. The market therefore covers any cosmetic product where NMN is deliberately added and highlighted in the formula or marketing story—serums, lotions, creams, facial masks, eye products, hand or body creams, and sometimes specialty items such as biocellulose masks or treatment ampoules—rather than oral supplements or general NAD⁺ boosters, which belong to the nutraceutical category.

The Nicotinamide Mononucleotide (NMN) Cosmetics industry chain runs from upstream suppliers of cosmetic-grade NMN (derived from vitamin B3/nicotinamide and fermentation raw materials), emollients, humectants, surfactants, packaging and mask substrates, through midstream cosmetic formulators and OEM/ODM manufacturers that develop serums, creams, facial masks, eye and body products, to downstream brand owners, e-commerce platforms, pharmacies, beauty retailers, clinics/spas and end-consumers using NMN cosmetics for anti-aging, moisturizing, brightening and “skin vitality” care.

In 2024, global Nicotinamide Mononucleotide (NMN) Cosmetics production reached approximately 17.4 million units, with an average global market price of around US$ 17.6 per unit. The global single-line production capacity ranges from 500 to1000 k units per year. The industry's gross profit margin is approximately 30%-35%.

North American market for Nicotinamide Mononucleotide (NMN) Cosmetics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nicotinamide Mononucleotide (NMN) Cosmetics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics include Natuore Recover, Mirailab Bioscience, Eurea, LUERLING, RubyBerries, Winkey Technology, GeneHarbor, Bontac, EffePharm, Bloomage Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN) Cosmetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN) Cosmetics.

The Nicotinamide Mononucleotide (NMN) Cosmetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicotinamide Mononucleotide (NMN) Cosmetics market comprehensively. Regional market sizes, concerning products by Type, by Application, by Application Area and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nicotinamide Mononucleotide (NMN) Cosmetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Application Area and by regions.

Scope of Nicotinamide Mononucleotide (NMN) Cosmetics Market Report

Report Metric	Details
Report Name	Nicotinamide Mononucleotide (NMN) Cosmetics Market
Accounted market size in year	US$ 305 million
Forecasted market size in 2031	US$ 1158 million
CAGR	20.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Online Offline
Segment by Application Area	Facial Care Body Care Hair Care
Segment by Target Consumer Group	20s–30s Consumers 30s–40s Consumers Men Consumers Others
Segment by Core Functional Claim	Anti-aging Hydrating Brightening Others
Segment by Application	Facial Mask Essence Lotion Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Natuore Recover, Mirailab Bioscience, Eurea, LUERLING, RubyBerries, Winkey Technology, GeneHarbor, Bontac, EffePharm, Bloomage Biotechnology, Jiangxi Haiwen Biotechnology, Futide Health Management, Zein, Harbin Fuerjia Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicotinamide Mononucleotide (NMN) Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicotinamide Mononucleotide (NMN) Cosmetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nicotinamide Mononucleotide (NMN) Cosmetics Market growing?

Ans: The Nicotinamide Mononucleotide (NMN) Cosmetics Market witnessing a CAGR of 20.8% during the forecast period 2025-2031.

What is the Nicotinamide Mononucleotide (NMN) Cosmetics Market size in 2031?

Ans: The Nicotinamide Mononucleotide (NMN) Cosmetics Market size in 2031 will be US$ 1158 million.

Who are the main players in the Nicotinamide Mononucleotide (NMN) Cosmetics Market report?

Ans: The main players in the Nicotinamide Mononucleotide (NMN) Cosmetics Market are Natuore Recover, Mirailab Bioscience, Eurea, LUERLING, RubyBerries, Winkey Technology, GeneHarbor, Bontac, EffePharm, Bloomage Biotechnology, Jiangxi Haiwen Biotechnology, Futide Health Management, Zein, Harbin Fuerjia Technology

What are the Application segmentation covered in the Nicotinamide Mononucleotide (NMN) Cosmetics Market report?

Ans: The Applications covered in the Nicotinamide Mononucleotide (NMN) Cosmetics Market report are Facial Mask, Essence, Lotion, Others

What are the Type segmentation covered in the Nicotinamide Mononucleotide (NMN) Cosmetics Market report?

Ans: The Types covered in the Nicotinamide Mononucleotide (NMN) Cosmetics Market report are Online, Offline

1 Nicotinamide Mononucleotide (NMN) Cosmetics Market Overview

1.1 Product Definition

1.2 Nicotinamide Mononucleotide (NMN) Cosmetics by Type

1.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Online

1.2.3 Offline

1.3 Nicotinamide Mononucleotide (NMN) Cosmetics by Application Area

1.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Application Area: 2024 VS 2031

1.3.2 Facial Care

1.3.3 Body Care

1.3.4 Hair Care

1.4 Nicotinamide Mononucleotide (NMN) Cosmetics by Target Consumer Group

1.4.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Target Consumer Group: 2024 VS 2031

1.4.2 20s–30s Consumers

1.4.3 30s–40s Consumers

1.4.4 Men Consumers

1.4.5 Others

1.5 Nicotinamide Mononucleotide (NMN) Cosmetics by Core Functional Claim

1.5.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Core Functional Claim: 2024 VS 2031

1.5.2 Anti-aging

1.5.3 Hydrating

1.5.4 Brightening

1.5.5 Others

1.6 Nicotinamide Mononucleotide (NMN) Cosmetics by Application

1.6.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Application (2024 VS 2031)

1.6.2 Facial Mask

1.6.3 Essence

1.6.4 Lotion

1.6.5 Others

1.7 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size Estimates and Forecasts

1.7.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue 2020-2031

1.7.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales 2020-2031

1.7.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Average Price (2020-2031)

1.8 Assumptions and Limitations

2 Nicotinamide Mononucleotide (NMN) Cosmetics Market Competition by Manufacturers

2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nicotinamide Mononucleotide (NMN) Cosmetics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Product Type & Application

2.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Date of Enter into This Industry

2.8 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Competitive Situation and Trends

2.8.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nicotinamide Mononucleotide (NMN) Cosmetics Players Market Share by Revenue

2.8.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Scenario by Region

3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region: 2020-2031

3.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region: 2020-2025

3.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region: 2026-2031

3.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region: 2020-2031

3.3.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region: 2020-2025

3.3.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region: 2026-2031

3.4 North America Nicotinamide Mononucleotide (NMN) Cosmetics Market Facts & Figures by Country

3.4.1 North America Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2031)

3.4.3 North America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Market Facts & Figures by Country

3.5.1 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2031)

3.5.3 Europe Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Market Facts & Figures by Region

3.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region (2020-2031)

3.6.3 Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Market Facts & Figures by Country

3.7.1 Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2031)

3.7.3 Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Market Facts & Figures by Country

3.8.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Type (2020-2031)

4.1.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Type (2020-2025)

4.1.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Type (2026-2031)

4.1.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Type (2020-2031)

4.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Type (2020-2031)

4.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Type (2020-2025)

4.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Type (2026-2031)

4.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Type (2020-2031)

4.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Application (2020-2031)

5.1.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Application (2020-2025)

5.1.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Application (2026-2031)

5.1.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Application (2020-2031)

5.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Application (2020-2031)

5.2.1 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Application (2020-2025)

5.2.2 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Application (2026-2031)

5.2.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Application (2020-2031)

5.3 Global Nicotinamide Mononucleotide (NMN) Cosmetics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Natuore Recover

6.1.1 Natuore Recover Company Information

6.1.2 Natuore Recover Description and Business Overview

6.1.3 Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.1.5 Natuore Recover Recent Developments/Updates

6.2 Mirailab Bioscience

6.2.1 Mirailab Bioscience Company Information

6.2.2 Mirailab Bioscience Description and Business Overview

6.2.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.2.5 Mirailab Bioscience Recent Developments/Updates

6.3 Eurea

6.3.1 Eurea Company Information

6.3.2 Eurea Description and Business Overview

6.3.3 Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.3.5 Eurea Recent Developments/Updates

6.4 LUERLING

6.4.1 LUERLING Company Information

6.4.2 LUERLING Description and Business Overview

6.4.3 LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.4.5 LUERLING Recent Developments/Updates

6.5 RubyBerries

6.5.1 RubyBerries Company Information

6.5.2 RubyBerries Description and Business Overview

6.5.3 RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.5.5 RubyBerries Recent Developments/Updates

6.6 Winkey Technology

6.6.1 Winkey Technology Company Information

6.6.2 Winkey Technology Description and Business Overview

6.6.3 Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.6.5 Winkey Technology Recent Developments/Updates

6.7 GeneHarbor

6.7.1 GeneHarbor Company Information

6.7.2 GeneHarbor Description and Business Overview

6.7.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.7.5 GeneHarbor Recent Developments/Updates

6.8 Bontac

6.8.1 Bontac Company Information

6.8.2 Bontac Description and Business Overview

6.8.3 Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.8.5 Bontac Recent Developments/Updates

6.9 EffePharm

6.9.1 EffePharm Company Information

6.9.2 EffePharm Description and Business Overview

6.9.3 EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.9.5 EffePharm Recent Developments/Updates

6.10 Bloomage Biotechnology

6.10.1 Bloomage Biotechnology Company Information

6.10.2 Bloomage Biotechnology Description and Business Overview

6.10.3 Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.10.5 Bloomage Biotechnology Recent Developments/Updates

6.11 Jiangxi Haiwen Biotechnology

6.11.1 Jiangxi Haiwen Biotechnology Company Information

6.11.2 Jiangxi Haiwen Biotechnology Description and Business Overview

6.11.3 Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.11.5 Jiangxi Haiwen Biotechnology Recent Developments/Updates

6.12 Futide Health Management

6.12.1 Futide Health Management Company Information

6.12.2 Futide Health Management Description and Business Overview

6.12.3 Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.12.5 Futide Health Management Recent Developments/Updates

6.13 Zein

6.13.1 Zein Company Information

6.13.2 Zein Description and Business Overview

6.13.3 Zein Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Zein Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.13.5 Zein Recent Developments/Updates

6.14 Harbin Fuerjia Technology

6.14.1 Harbin Fuerjia Technology Company Information

6.14.2 Harbin Fuerjia Technology Description and Business Overview

6.14.3 Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product Portfolio

6.14.5 Harbin Fuerjia Technology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nicotinamide Mononucleotide (NMN) Cosmetics Industry Chain Analysis

7.2 Nicotinamide Mononucleotide (NMN) Cosmetics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nicotinamide Mononucleotide (NMN) Cosmetics Production Mode & Process Analysis

7.4 Nicotinamide Mononucleotide (NMN) Cosmetics Sales and Marketing

7.4.1 Nicotinamide Mononucleotide (NMN) Cosmetics Sales Channels

7.4.2 Nicotinamide Mononucleotide (NMN) Cosmetics Distributors

7.5 Nicotinamide Mononucleotide (NMN) Cosmetics Customer Analysis

8 Nicotinamide Mononucleotide (NMN) Cosmetics Market Dynamics

8.1 Nicotinamide Mononucleotide (NMN) Cosmetics Industry Trends

8.2 Nicotinamide Mononucleotide (NMN) Cosmetics Market Drivers

8.3 Nicotinamide Mononucleotide (NMN) Cosmetics Market Challenges

8.4 Nicotinamide Mononucleotide (NMN) Cosmetics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bloomage BioTechnology

Jiangxi Haiwen Biotechnology

Zein

Harbin Fuerjia Technology

Eurea

Futide Health Management

List of Tables

Table 1. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Application Area, (US$ Million) & (2024 VS 2031)

Table 3. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Target Consumer Group, (US$ Million) & (2024 VS 2031)

Table 4. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Core Functional Claim, (US$ Million) & (2024 VS 2031)

Table 5. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 6. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Competitive Situation by Manufacturers in 2024

Table 7. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units) of Key Manufacturers (2020-2025)

Table 8. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Manufacturers (2020-2025)

Table 9. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 10. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Share by Manufacturers (2020-2025)

Table 11. Global Market Nicotinamide Mononucleotide (NMN) Cosmetics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 12. Global Key Players of Nicotinamide Mononucleotide (NMN) Cosmetics, Industry Ranking, 2022 VS 2023 VS 2024

Table 13. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Manufacturing Sites & Headquarters

Table 14. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Product Type & Application

Table 15. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Cosmetics, Date of Enter into This Industry

Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Nicotinamide Mononucleotide (NMN) Cosmetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) Cosmetics as of 2024)

Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 19. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 20. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region (2020-2025) & (K Units)

Table 21. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Region (2020-2025)

Table 22. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region (2026-2031) & (K Units)

Table 23. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Region (2026-2031)

Table 24. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region (2020-2025) & (US$ Million)

Table 25. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Region (2020-2025)

Table 26. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region (2026-2031) & (US$ Million)

Table 27. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Region (2026-2031)

Table 28. North America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2025) & (K Units)

Table 30. North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2026-2031) & (K Units)

Table 31. North America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2025) & (US$ Million)

Table 32. North America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2026-2031) & (US$ Million)

Table 33. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 34. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2025) & (K Units)

Table 35. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2026-2031) & (K Units)

Table 36. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2025) & (US$ Million)

Table 37. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2026-2031) & (US$ Million)

Table 38. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 39. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region (2020-2025) & (K Units)

Table 40. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Region (2026-2031) & (K Units)

Table 41. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region (2020-2025) & (US$ Million)

Table 42. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2025) & (K Units)

Table 45. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2026-2031) & (K Units)

Table 46. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2025) & (US$ Million)

Table 47. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2026-2031) & (US$ Million)

Table 48. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2020-2025) & (K Units)

Table 50. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales by Country (2026-2031) & (K Units)

Table 51. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2020-2025) & (US$ Million)

Table 52. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Revenue by Country (2026-2031) & (US$ Million)

Table 53. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units) by Type (2020-2025)

Table 54. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units) by Type (2026-2031)

Table 55. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Type (2020-2025)

Table 56. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Type (2026-2031)

Table 57. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue (US$ Million) by Type (2020-2025)

Table 58. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue (US$ Million) by Type (2026-2031)

Table 59. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Type (2020-2025)

Table 60. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Type (2026-2031)

Table 61. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Type (2020-2025)

Table 62. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Type (2026-2031)

Table 63. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units) by Application (2020-2025)

Table 64. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units) by Application (2026-2031)

Table 65. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Application (2020-2025)

Table 66. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Application (2026-2031)

Table 67. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue (US$ Million) by Application (2020-2025)

Table 68. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue (US$ Million) by Application (2026-2031)

Table 69. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Application (2020-2025)

Table 70. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Application (2026-2031)

Table 71. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Application (2020-2025)

Table 72. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Application (2026-2031)

Table 73. Natuore Recover Company Information

Table 74. Natuore Recover Description and Business Overview

Table 75. Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 76. Natuore Recover Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 77. Natuore Recover Recent Developments/Updates

Table 78. Mirailab Bioscience Company Information

Table 79. Mirailab Bioscience Description and Business Overview

Table 80. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 82. Mirailab Bioscience Recent Developments/Updates

Table 83. Eurea Company Information

Table 84. Eurea Description and Business Overview

Table 85. Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 86. Eurea Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 87. Eurea Recent Developments/Updates

Table 88. LUERLING Company Information

Table 89. LUERLING Description and Business Overview

Table 90. LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 91. LUERLING Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 92. LUERLING Recent Developments/Updates

Table 93. RubyBerries Company Information

Table 94. RubyBerries Description and Business Overview

Table 95. RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. RubyBerries Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 97. RubyBerries Recent Developments/Updates

Table 98. Winkey Technology Company Information

Table 99. Winkey Technology Description and Business Overview

Table 100. Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 101. Winkey Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 102. Winkey Technology Recent Developments/Updates

Table 103. GeneHarbor Company Information

Table 104. GeneHarbor Description and Business Overview

Table 105. GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 106. GeneHarbor Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 107. GeneHarbor Recent Developments/Updates

Table 108. Bontac Company Information

Table 109. Bontac Description and Business Overview

Table 110. Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 111. Bontac Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 112. Bontac Recent Developments/Updates

Table 113. EffePharm Company Information

Table 114. EffePharm Description and Business Overview

Table 115. EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 116. EffePharm Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 117. EffePharm Recent Developments/Updates

Table 118. Bloomage Biotechnology Company Information

Table 119. Bloomage Biotechnology Description and Business Overview

Table 120. Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 121. Bloomage Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 122. Bloomage Biotechnology Recent Developments/Updates

Table 123. Jiangxi Haiwen Biotechnology Company Information

Table 124. Jiangxi Haiwen Biotechnology Description and Business Overview

Table 125. Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 126. Jiangxi Haiwen Biotechnology Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 127. Jiangxi Haiwen Biotechnology Recent Developments/Updates

Table 128. Futide Health Management Company Information

Table 129. Futide Health Management Description and Business Overview

Table 130. Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 131. Futide Health Management Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 132. Futide Health Management Recent Developments/Updates

Table 133. Zein Company Information

Table 134. Zein Description and Business Overview

Table 135. Zein Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 136. Zein Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 137. Zein Recent Developments/Updates

Table 138. Harbin Fuerjia Technology Company Information

Table 139. Harbin Fuerjia Technology Description and Business Overview

Table 140. Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 141. Harbin Fuerjia Technology Nicotinamide Mononucleotide (NMN) Cosmetics Product

Table 142. Harbin Fuerjia Technology Recent Developments/Updates

Table 143. Key Raw Materials Lists

Table 144. Raw Materials Key Suppliers Lists

Table 145. Nicotinamide Mononucleotide (NMN) Cosmetics Distributors List

Table 146. Nicotinamide Mononucleotide (NMN) Cosmetics Customers List

Table 147. Nicotinamide Mononucleotide (NMN) Cosmetics Market Trends

Table 148. Nicotinamide Mononucleotide (NMN) Cosmetics Market Drivers

Table 149. Nicotinamide Mononucleotide (NMN) Cosmetics Market Challenges

Table 150. Nicotinamide Mononucleotide (NMN) Cosmetics Market Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nicotinamide Mononucleotide (NMN) Cosmetics

Figure 2. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Type: 2024 & 2031

Figure 4. Online Product Picture

Figure 5. Offline Product Picture

Figure 6. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Application Area, (US$ Million) & (2020-2031)

Figure 7. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Application Area: 2024 VS 2031

Figure 8. Facial Care Product Picture

Figure 9. Body Care Product Picture

Figure 10. Hair Care Product Picture

Figure 11. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Target Consumer Group, (US$ Million) & (2020-2031)

Figure 12. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Target Consumer Group: 2024 VS 2031

Figure 13. 20s–30s Consumers Product Picture

Figure 14. 30s–40s Consumers Product Picture

Figure 15. Men Consumers Product Picture

Figure 16. Others Product Picture

Figure 17. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Core Functional Claim, (US$ Million) & (2020-2031)

Figure 18. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Core Functional Claim: 2024 VS 2031

Figure 19. Anti-aging Product Picture

Figure 20. Hydrating Product Picture

Figure 21. Brightening Product Picture

Figure 22. Others Product Picture

Figure 23. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Value by Application (2020-2031) & (US$ Million)

Figure 24. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Application: 2024 & 2031

Figure 25. Facial Mask

Figure 26. Essence

Figure 27. Lotion

Figure 28. Others

Figure 29. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 30. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size (2020-2031) & (US$ Million)

Figure 31. Global Nicotinamide Mononucleotide (NMN) Cosmetics Sales (2020-2031) & (K Units)

Figure 32. Global Nicotinamide Mononucleotide (NMN) Cosmetics Average Price (US$/Unit) & (2020-2031)

Figure 33. Nicotinamide Mononucleotide (NMN) Cosmetics Report Years Considered

Figure 34. Nicotinamide Mononucleotide (NMN) Cosmetics Sales Share by Manufacturers in 2024

Figure 35. Global Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Share by Manufacturers in 2024

Figure 36. Global 5 and 10 Largest Nicotinamide Mononucleotide (NMN) Cosmetics Players: Market Share by Revenue in Nicotinamide Mononucleotide (NMN) Cosmetics in 2024

Figure 37. Nicotinamide Mononucleotide (NMN) Cosmetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Global Nicotinamide Mononucleotide (NMN) Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 39. North America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Country (2020-2031)

Figure 40. North America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Country (2020-2031)

Figure 41. United States Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Canada Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Country (2020-2031)

Figure 44. Europe Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Country (2020-2031)

Figure 45. Germany Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. France Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. U.K. Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Italy Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Russia Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Region (2020-2031)

Figure 51. Asia Pacific Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Region (2020-2031)

Figure 52. China Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Japan Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. South Korea Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. India Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Australia Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. China Taiwan Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Southeast Asia Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Country (2020-2031)

Figure 60. Latin America Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Country (2020-2031)

Figure 61. Mexico Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 62. Brazil Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 63. Argentina Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 64. Colombia Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 65. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Sales Market Share by Country (2020-2031)

Figure 66. Middle East and Africa Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Market Share by Country (2020-2031)

Figure 67. Turkey Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 68. Saudi Arabia Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 69. UAE Nicotinamide Mononucleotide (NMN) Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 70. Global Sales Market Share of Nicotinamide Mononucleotide (NMN) Cosmetics by Type (2020-2031)

Figure 71. Global Revenue Market Share of Nicotinamide Mononucleotide (NMN) Cosmetics by Type (2020-2031)

Figure 72. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Type (2020-2031)

Figure 73. Global Sales Market Share of Nicotinamide Mononucleotide (NMN) Cosmetics by Application (2020-2031)

Figure 74. Global Revenue Market Share of Nicotinamide Mononucleotide (NMN) Cosmetics by Application (2020-2031)

Figure 75. Global Nicotinamide Mononucleotide (NMN) Cosmetics Price (US$/Unit) by Application (2020-2031)

Figure 76. Nicotinamide Mononucleotide (NMN) Cosmetics Value Chain

Figure 77. Channels of Distribution (Direct Vs Distribution)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions